Package 61037-479-04

Brand: cetirizine hydrochloride

Generic: cetirizine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 61037-479-04
Digits Only 6103747904
Product NDC 61037-479
Description

240 mL in 1 BOTTLE, PLASTIC (61037-479-04)

Marketing

Marketing Status
Marketed Since 2025-06-06
Brand cetirizine hydrochloride
Generic cetirizine hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3b5908fd-b2c0-ba45-e063-6294a90a6fb0", "openfda": {"upc": ["0361037479048"], "unii": ["64O047KTOA"], "rxcui": ["1014673"], "spl_set_id": ["3b5908f1-faba-c317-e063-6294a90aa8a7"], "manufacturer_name": ["BAJAJ MEDICAL, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "240 mL in 1 BOTTLE, PLASTIC (61037-479-04)", "package_ndc": "61037-479-04", "marketing_start_date": "20250606"}], "brand_name": "CETIRIZINE HYDROCHLORIDE", "product_id": "61037-479_3b5908fd-b2c0-ba45-e063-6294a90a6fb0", "dosage_form": "SOLUTION", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "61037-479", "generic_name": "CETIRIZINE HYDROCHLORIDE", "labeler_name": "BAJAJ MEDICAL, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CETIRIZINE HYDROCHLORIDE", "active_ingredients": [{"name": "CETIRIZINE HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "ANDA090191", "marketing_category": "ANDA", "marketing_start_date": "20230912", "listing_expiration_date": "20261231"}